1999 M&A activity

The following 60 biotech mergers and acquisitions in 1999 have an aggregate value of $19.1 billion, with an average size of $317.8 million. The table excludes 13 mergers or acquisitions that did not include deal terms. Also not included are pharma-to-pharma deals, CRO deals, reverse mergers, purchases of portions of businesses, which include the purchase of an